1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Mevalonate Kinase Deficiency: new trials by email Literature Review of Mevalonate Kinase Deficiency trials Research Report on Mevalonate Kinase Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies canakinumab - Systemic Juvenile Idiopathic Arthritis, Hereditary Periodic Fevers | Phase 3 | Completed | Novartis Pharmaceuticals | 31 | 2014-11-03 | 2020-05-19 |
Arthralgia (1) · Arthritis, Juvenile (1) · Bronchiolitis Obliterans Syndrome (1) · Cryopyrin-Associated Periodic Syndromes (1) · Rheumatoid Arthritis, Systemic Juvenile (1)
Arthritis (1) · Autoimmune Diseases (1) · Blood Protein Disorders (1) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Chronic Inducible Urticaria (1) · Chronic Urticaria (1) · Cold Urticaria (1)
canakinumab (1)
France (1)
2014 (1)